reviewTop 1% cited
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Nature Reviews Drug Discovery · 2002 · Vol. 1(4) · pp. 287–299
Ricky W. Johnstone✉(University of St Andrews)
Histone Deacetylase Inhibitors ResearchProtein Degradation and InhibitorsUbiquitin and proteasome pathwaysHistone deacetylaseHistone AcetyltransferasesHistoneHistone deacetylase 5Cancer researchHDAC11ChromatinChromatin remodelingBiologyHDAC10
MeSH terms
AcetylationAnimalsAntineoplastic AgentsCell DifferentiationChromatinClinical Trials as TopicEnzyme InhibitorsHistonesHumansNeoplasmsGene Expression Regulation, NeoplasticApoptosisDNA MethylationHistone Deacetylase Inhibitors
Funding
- Wellcome Trust
- National Health and Medical Research Council
- National Medical Research Council
Citations
1,513
FWCI
28.08
field-weighted impact
References
123
Percentile
100%
vs. same field & year
Citations per year
Cited by
Histone deacetylases (HDACs): characterization of the classical HDAC family
Biochemical Journal · 2003 · 3,077 citations
Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
Molecules · 2015 · 673 citations
Anticancer activities of histone deacetylase inhibitors
Nature Reviews Drug Discovery · 2006 · 2,905 citations
Multi-targeted prevention of cancer by sulforaphane
Cancer Letters · 2008 · 551 citations
Drug discovery from medicinal plants
Life Sciences · 2005 · 1,797 citations
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Nature Reviews Drug Discovery · 2014 · 1,501 citations
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Cell · 2016 · 6,324 citations
Regulation of histone deacetylase activities
Journal of Cellular Biochemistry · 2004 · 345 citations
References
CBP/p300 in cell growth, transformation, and development
Genes & Development · 2000 · 1,757 citations
Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours
The Journal of Pathology · 2001 · 748 citations
The Human Histone Deacetylase Family
Experimental Cell Research · 2001 · 547 citations
The Hallmarks of Cancer
Cell · 2000 · 28,385 citations
Histone deacetylases, transcriptional control, and cancer
Journal of Cellular Physiology · 2000 · 622 citations
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
The EMBO Journal · 2001 · 1,871 citations
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
JNCI Journal of the National Cancer Institute · 2000 · 1,162 citations
Translating the Histone Code
Science · 2001 · 9,632 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.